271 related articles for article (PubMed ID: 25590679)
1. Supplement use and other characteristics among pregnant women with a previous pregnancy affected by a neural tube defect - United States, 1997-2009.
Arth A; Tinker S; Moore C; Canfield M; Agopian A; Reefhuis J;
MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):6-9. PubMed ID: 25590679
[TBL] [Abstract][Full Text] [Related]
2. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011.
Williams J; Mai CT; Mulinare J; Isenburg J; Flood TJ; Ethen M; Frohnert B; Kirby RS;
MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):1-5. PubMed ID: 25590678
[TBL] [Abstract][Full Text] [Related]
3. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.
Wilson RD; ; Wilson RD; Audibert F; Brock JA; Carroll J; Cartier L; Gagnon A; Johnson JA; Langlois S; Murphy-Kaulbeck L; Okun N; Pastuck M; ; Deb-Rinker P; Dodds L; Leon JA; Lowel HL; Luo W; MacFarlane A; McMillan R; Moore A; Mundle W; O'Connor D; Ray J; Van den Hof M
J Obstet Gynaecol Can; 2015 Jun; 37(6):534-52. PubMed ID: 26334606
[TBL] [Abstract][Full Text] [Related]
4. When folic acid fails: Insights from 20 years of neural tube defect surveillance in South Carolina.
Bupp CP; Sarasua SM; Dean JH; Stevenson RE
Am J Med Genet A; 2015 Oct; 167A(10):2244-50. PubMed ID: 26108864
[TBL] [Abstract][Full Text] [Related]
5. Modeling the impact of folic acid fortification and supplementation on red blood cell folate concentrations and predicted neural tube defect risk in the United States: have we reached optimal prevention?
Crider KS; Qi YP; Devine O; Tinker SC; Berry RJ
Am J Clin Nutr; 2018 Jun; 107(6):1027-1034. PubMed ID: 29767673
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, use, and education regarding folic acid supplementation: continuation study of women in Colorado who had a pregnancy affected by a neural tube defect.
Rinsky-Eng J; Miller L
Teratology; 2002; 66 Suppl 1():S29-31. PubMed ID: 12239741
[TBL] [Abstract][Full Text] [Related]
7. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 May; 53(17):362-5. PubMed ID: 15129193
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and neural tube defect recurrence prevention.
Grosse SD; Collins JS
Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):737-42. PubMed ID: 17990333
[TBL] [Abstract][Full Text] [Related]
9. Trends in Multivitamin Use Among Women of Reproductive Age: United States, 2006-2016.
Wong EC; Rose CE; Flores AL; Yeung LF
J Womens Health (Larchmt); 2019 Jan; 28(1):37-45. PubMed ID: 30620242
[TBL] [Abstract][Full Text] [Related]
10. Folic acid awareness and use among women with a history of a neural tube defect pregnancy--Texas, 2000-2001.
Canfield MA; Anderson JL; Waller DK; Palmer SE; Kaye CI
MMWR Recomm Rep; 2002 Sep; 51(RR-13):16-9. PubMed ID: 12353508
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of a neural tube defect recurrence-prevention program.
Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE
Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of neural tube defects and folic acid knowledge and consumption--Puerto Rico, 1996-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Jan; 57(1):10-3. PubMed ID: 18185495
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid.
Zlotogora J; Amitai Y; Leventhal A
Isr Med Assoc J; 2006 Sep; 8(9):601-4. PubMed ID: 17058407
[TBL] [Abstract][Full Text] [Related]
14. Neural tube defects: knowledge and preconceptional prevention practices in minority young women.
Chacko MR; Anding R; Kozinetz CA; Grover JL; Smith PB
Pediatrics; 2003 Sep; 112(3 Pt 1):536-42. PubMed ID: 12949280
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force.
Wolff T; Witkop CT; Miller T; Syed SB;
Ann Intern Med; 2009 May; 150(9):632-9. PubMed ID: 19414843
[TBL] [Abstract][Full Text] [Related]
16. Knowledge and use of folic acid supplementation: a study of Colorado women whose pregnancies were affected by a fetal neural tube defect.
Callender ES; Rickard R; Miller L; Rinsky-Eng J
Clin Invest Med; 2001 Jun; 24(3):124-8. PubMed ID: 11437063
[TBL] [Abstract][Full Text] [Related]
17. The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States.
Dietrich M; Brown CJ; Block G
J Am Coll Nutr; 2005 Aug; 24(4):266-74. PubMed ID: 16093404
[TBL] [Abstract][Full Text] [Related]
18. Race and ethnicity and preconception folic acid supplement use among pregnant women in Georgia, PRAMS 2009 to 2011.
Mukhtar A; Kramer MR; Oakley GP; Kancherla V
Birth Defects Res; 2017 Jan; 109(1):38-48. PubMed ID: 27905191
[TBL] [Abstract][Full Text] [Related]
19. Decline in prevalence of neural tube defects in a high-risk region of the United States.
Stevenson RE; Allen WP; Pai GS; Best R; Seaver LH; Dean J; Thompson S
Pediatrics; 2000 Oct; 106(4):677-83. PubMed ID: 11015508
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and prevention of birth defects.
Green NS
J Nutr; 2002 Aug; 132(8 Suppl):2356S-2360S. PubMed ID: 12163692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
